Figure 5
Figure 5. MK binding to PMNs did not require CD18 or CD29. (A-C) Analysis of binding of Alexa Fluor 488-labeled MK to murine PMNs using flow cytometry. For control, PMNs were left unstained. (A-B) Cells were left untreated for control (w/o) or stimulated with TNF-α (100 ng/ml), CXCL1 (100 ng/ml), or MnCl2 (3 mM) for 20 minutes at 37°C. (A) Binding of MK to isolated PMNs from CD18+/+ or CD18−/− mice. (B) Binding of MK to isolated PMNs from CD29+/+ or CD29−/− mice. (C) Binding of MK to PMNs from WT mice. The α4 subunit was blocked with the anti-CD49d antibody or left unblocked (untreated), and the rat IgG2b antibody was used as control. Blocking was performed for 20 minutes at RT and cells were subsequently left unstimulated (w/o) or stimulated with TNF-α (100 ng/ml), or CXCL1 (100 ng/ml) for 20 minutes at 37°C. Histograms (A-C) are representative of 3 independent experiments.

MK binding to PMNs did not require CD18 or CD29. (A-C) Analysis of binding of Alexa Fluor 488-labeled MK to murine PMNs using flow cytometry. For control, PMNs were left unstained. (A-B) Cells were left untreated for control (w/o) or stimulated with TNF-α (100 ng/ml), CXCL1 (100 ng/ml), or MnCl2 (3 mM) for 20 minutes at 37°C. (A) Binding of MK to isolated PMNs from CD18+/+ or CD18−/− mice. (B) Binding of MK to isolated PMNs from CD29+/+ or CD29−/− mice. (C) Binding of MK to PMNs from WT mice. The α4 subunit was blocked with the anti-CD49d antibody or left unblocked (untreated), and the rat IgG2b antibody was used as control. Blocking was performed for 20 minutes at RT and cells were subsequently left unstimulated (w/o) or stimulated with TNF-α (100 ng/ml), or CXCL1 (100 ng/ml) for 20 minutes at 37°C. Histograms (A-C) are representative of 3 independent experiments.

Close Modal

or Create an Account

Close Modal
Close Modal